“In emergency use, we have now used it for nearly a million people. We have not received any reports of serious side effects, and only a few have some mild symptoms,” Liu said.
Liu said the vaccine was given to Chinese construction workers, diplomats and students who have gone to more than 150 countries around the world during the pandemic – and none of them have reported an infection.
He said on November 6 that there were 56,000 people who had received emergency vaccinations and then traveled abroad.
“For example, a transnational firm has 99 employees in one of its overseas offices, 81
He said Sinopharm had individually conducted Phase 3 clinical trials with nearly 60,000 people in 10 countries – including the UAE, Bahrain, Egypt, Jordan, Peru and Argentina. CNN has not seen the results of these trials yet.
Sinopharm has two vaccine candidates. It is unclear which vaccine Liu was referring to.
Since July, Chinese drug manufacturers have administered experimental vaccines to people working in “high-risk” occupations under the emergency use program, allowing vaccine candidates to be used to a limited extent before their safety and efficacy are fully proven in clinical trials.
Pfizer is expected to apply to the U.S. Food and Drug Administration for emergency use of its vaccine Friday.
Dr. Anthony Fauci, the leading US expert on infectious diseases, said the Pfizer and Moderna vaccines had shown extraordinary efficacy.
“It’s extraordinary,” Fauci said. “It’s almost on par with what we see with measles (vaccine), which is 98% effective.”
CNN’s Beijing Bureau contributed to this article.